doi: 10.1039/d1ra90067f.
Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
Affiliations
- PMID: 35427065
- PMCID: PMC8694806
- DOI: 10.1039/d1ra90067f
Item in Clipboard
Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
RSC Adv.
.
Abstract
[This retracts the article DOI: 10.1039/C8RA00296G.].
This journal is © The Royal Society of Chemistry.
Retraction of
-
Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4.RSC Adv. 2018 Feb 23;8(16):8455-8468. doi: 10.1039/c8ra00296g. eCollection 2018 Feb 23. RSC Adv. 2018. Retraction in: RSC Adv. 2021 Feb 2;11(11):5895. doi: 10.1039/d1ra90067f. PMID: 35539872 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
